Morphine Sulfate Injection
Brand names: Duramorph, Infumorph 200, Infumorph 500, Mitigo, Morphine Sulfate
Category: Analgesia/Addiction
Unavailable 11Limited 1Available 12
FDA status: Current · Last FDA update: Sep 22, 2026 · First posted: Oct 31, 2017 (in shortage 8 years 11 months) · 5 manufacturers, 24 listed presentations
As of Sep 22, 2026, the FDA lists Morphine Sulfate Injection as currently in shortage. Of 24 manufacturer presentations, 11 Unavailable, 1 Limited, 12 Available.
Ask your pharmacist: which of the 5 manufacturers below can they order right now, and whether a different strength or form of Morphine Sulfate Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Duramorph, Injection, .5 mg/1 mL (NDC 0641-6020-10) NDC 0641-6020-10 |
Hikma Pharmaceuticals USA, Inc. | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. |
| Morphine Sulfate, Injection, 1 mg/1 mL (NDC 76329-1912-1) NDC 76329-1912-1 |
Amphastar Pharmaceuticals, Inc. | Available | - |
| Duramorph, Injection, 1 mg/1 mL (NDC 0641-6019-10) NDC 0641-6019-10 |
Hikma Pharmaceuticals USA, Inc. | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. |
| Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01) NDC 63323-452-01 |
Fresenius Kabi USA, LLC | Unavailable | Next release September 2026. Check wholesalers for inventory. |
| Morphine Sulfate, Injection, 2 mg/1 mL (NDC 76045-004-11) NDC 76045-004-11 |
Fresenius Kabi USA, LLC | Unavailable | Next release September 2026. Check wholesalers for inventory. |
| Morphine Sulfate, Injection, 2 mg/1 mL (NDC 0409-1890-23) NDC 0409-1890-23 |
Hospira, Inc., a Pfizer Company | Limited | Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay |
| Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01) NDC 0409-1890-01 |
Hospira, Inc., a Pfizer Company | Available | - |
| Morphine Sulfate, Injection, 4 mg/1 mL (NDC 76045-005-11) NDC 76045-005-11 |
Fresenius Kabi USA, LLC | Unavailable | Next release September 2026. Check wholesalers for inventory. |
| Morphine Sulfate, Injection, 4 mg/1 mL (NDC 63323-454-01) NDC 63323-454-01 |
Fresenius Kabi USA, LLC | Unavailable | Next release October 2026. Check wholesalers for inventory. |
| Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0641-6125-25) NDC 0641-6125-25 |
Hikma Pharmaceuticals USA, Inc. | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. |
| Morphine Sulfate, Injection, 4 mg/1 mL Syringes (NDC 0409-1891-01) NDC 0409-1891-01 |
Hospira, Inc., a Pfizer Company | Available | - |
| Morphine Sulfate, Injection, 5 mg/1 mL (NDC 63323-455-01) NDC 63323-455-01 |
Fresenius Kabi USA, LLC | Unavailable | Estimated recovery: TBD |
| Morphine Sulfate, Injection, 8 mg/1 mL (NDC 0641-6126-25) NDC 0641-6126-25 |
Hikma Pharmaceuticals USA, Inc. | Unavailable | Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released. |
| Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01) NDC 0641-6039-01 |
Hikma Pharmaceuticals USA, Inc. | Unavailable | Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released. |
| Morphine Sulfate, Injection, 10 mg/1 mL (NDC 0641-6127-25) NDC 0641-6127-25 |
Hikma Pharmaceuticals USA, Inc. | Unavailable | Additional lots are scheduled to be manufactured. Product will be made available as it is released. |
| Morphine Sulfate, Injection, 10 mg/1 mL (NDC 63323-451-01) NDC 63323-451-01 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01) NDC 0409-1893-01 |
Hospira, Inc., a Pfizer Company | Unavailable | Discontinuation of the manufacture of the drug |
| Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1 mL (NDC 0641-6040-01) NDC 0641-6040-01 |
Hikma Pharmaceuticals USA, Inc. | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. |
| Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1896-20) NDC 0409-1896-20 |
Hospira, Inc., a Pfizer Company | Unavailable | Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay |
| Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-2022-01) NDC 0409-2022-01 |
Hospira, Inc., a Pfizer Company | Unavailable | Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay |
| Mitigo, Injection, 200 mg/20 mL (NDC 66794-160-02) NDC 66794-160-02 |
Piramal Critical Care Inc. | Available | - |
| Mitigo, Injection, 500 mg/20 mL (NDC 66794-162-02) NDC 66794-162-02 |
Piramal Critical Care Inc. | Available | - |
| Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12) NDC 0409-3815-12 |
Hospira, Inc., a Pfizer Company | Available | - |
| Morphine Sulfate, Injection, 5 mg/10 mL (0.5 mg/mL) (NDC 0409-3814-12) NDC 0409-3814-12 |
Hospira, Inc., a Pfizer Company | Available | - |
Related medications in shortage
Other Analgesia/Addiction medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Morphine Sulfate Injection (FDA data as of Sep 22, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Morphine Sulfate Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Check your inbox - click the confirmation link to activate
alerts for Morphine Sulfate Injection.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/morphine-sulfate-injection.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).